GlobeNewswire Inc.··NaMDxHealth's GPS Test Predicts Prostate Cancer Outcomes Across Treatment Settings
MDxHealth's genomic prostate cancer test demonstrates strong predictive performance across treatment settings, supporting path toward randomized clinical trial validation.
MDXHclinical trialprostate cancer